MedPath
FDA Approval

Methamphetamine Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 5, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Metamfetamine(5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Catalent Greenville, Inc.

Mayne Pharma Commercial LLC

118812386

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methamphetamine Hydrochloride

Product Details

NDC Product Code
68308-115
Application Number
ANDA091189
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 5, 2023
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
Code: 997F43Z9CVClass: ACTIBQuantity: 5 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath